Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific Antivirals

The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is ongoing and has shown the community that flexible methods for rapidly identifying and screening candidate antivirals are needed. Assessing virus-neutralizing activity of human serum to monitor popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Stelitano, Debora, Weisberg, Stuart P., Goldklang, Monica P., Zhu, Yun, Bovier, Francesca T., Kalantarov, Gavreel F., Greco, Giuseppe, Decimo, Didier, Franci, Gianluigi, Cennamo, Michele, Portella, Giuseppe, Galdiero, Massimiliano, Mathieu, Cyrille, Horvat, Branka, Trakht, Ilya N., Moscona, Anne, Whitt, Michael A., Porotto, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386372/
https://www.ncbi.nlm.nih.gov/pubmed/34319126
http://dx.doi.org/10.1128/mSphere.00571-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386372/
https://www.ncbi.nlm.nih.gov/pubmed/34319126
http://dx.doi.org/10.1128/mSphere.00571-21

Ejemplares similares